Winter triggered ailments no longer just a seasonal fluctuation but an escalating public health trigger due to air pollution, ...
Even at home, there may be risk factors that may be silently pushing you towards COPD. Find out what they are so that you can ...
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients ...
As temperatures drop and pollution rises, bronchitis quietly becomes the season’s most unwanted “guest” but unlike holiday ...
Introduction Inhaled therapy remains the mainstay of pharmacological treatment in COPD. Sub-optimal inhaler adherence leads to poorer clinical outcomes and unnecessary escalation of treatment. There ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback